Aarti Pharmalabs Q2 Results FY27: PAT Jumps 155.98% to Rs 71.47 Cr, Revenue Rs 610.45 Cr
- October 28, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Aarti Pharmalabs Q2 Results FY27 were declared on 28 October 2026, and the quarterly results show consolidated revenue of Rs 610.45 Cr, up 45.93% from Rs 418.33 Cr a year earlier. Net profit stood at Rs 71.47 Cr against Rs 27.92 Cr, a YoY growth of 155.98%. Operating Profit rose 80.89% to Rs 135.16 Cr. All figures are consolidated results for the July to September 2026 quarter.
Aarti Pharmalabs Ltd (AARTIPHARM) Q2 Results FY27 announced on 28 October 2026, covering the company’s financial performance for the July to September quarter. The company reported revenue of Rs 610.45 Cr and net profit of Rs 71.47 Cr on a Consolidated basis. The results date falls on the day the board met, and Aarti Pharmalabs Q2 Results FY27 are the consolidated results that investors on NSE and BSE can now compare with the same quarter last year.
This Aarti Pharmalabs Q2 Results results analysis covers the financial highlights, the business factors named in the disclosures, the FY27 outlook and the risks to track. Each section picks up from the one before it, starting with the Financial Highlights table that sets the revenue, Operating Profit and net profit side by side.
Click Here – Get Free Investment Predictions
Aarti Pharmalabs Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 610.45 Cr | Rs 418.33 Cr | +45.93% YoY |
| Operating Profit | Rs 135.16 Cr | Rs 74.72 Cr | +80.89% YoY |
| Net Profit (PAT) | Rs 71.47 Cr | Rs 27.92 Cr | +155.98% YoY |
Source: company filing for Aarti Pharmalabs Q2 Results FY27, 28 October 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Aarti Pharmalabs Q2 Results: What Stands Out
- Revenue of Rs 610.45 Cr is up 45.93% against Rs 418.33 Cr in the same quarter last year, a clear YoY growth in the top line.
- Net profit of Rs 71.47 Cr compares with Rs 27.92 Cr a year ago, an increase of 155.98% on a consolidated basis.
- Operating Profit of Rs 135.16 Cr is 80.89% higher than the Rs 74.72 Cr reported in the year-ago quarter.
- Net profit margin of 11.7% sits above the 6.7% recorded in the comparison quarter, so profit grew faster than revenue.
- Aarti Pharmalabs Q2 Results FY27 hand over to the performance analysis, which reads the revenue and profit lines together.
Aarti Pharmalabs Q2 Results FY27: Performance Analysis
The consolidated numbers show a quarter in which profit grew much faster than revenue. Revenue reached Rs 610.45 Cr against Rs 418.33 Cr, while net profit reached Rs 71.47 Cr against Rs 27.92 Cr. Aarti Pharmalabs Q2 Results FY27 therefore record revenue growth of 45.93% and net profit growth of 155.98% on a YoY basis.
Operating Profit followed the same direction and rose to Rs 135.16 Cr from Rs 74.72 Cr, a gain of 80.89%. Net profit margin moved to 11.7% from 6.7%, which shows how much of each rupee of revenue reached the bottom line in the latest quarter compared with the year-ago quarter.
For investors reading the Aarti Pharmalabs Q2 Results figures, the useful comparison is the gap between the three growth rates: 45.93% for revenue, 80.89% for Operating Profit and 155.98% for net profit. The quarterly results do not state the reason for that gap, which is where the results analysis turns to the business factors the company has disclosed.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth – The results analysis points to revenue growth of 45.9% year on year to Rs 610.45 Cr as the first business factor. A larger revenue base gave the quarter its starting point, and the quarterly results show that the top line moved up sharply from Rs 418.33 Cr.
Net Profit Expansion – Net profit rose 156.0% year on year to Rs 71.47 Cr, from Rs 27.92 Cr in the comparison quarter. This is the second factor, and it shows that the profit line expanded at a much faster pace than revenue in the same period.
Margin Improvement – Net profit margin improved to 11.7% from 6.7% in the comparison quarter. This margin move is the third factor and links the revenue and profit figures, because it measures profit as a share of revenue on a consolidated basis. Aarti Pharmalabs Q2 Results FY27 carry this margin figure.
FY27 Outlook After Aarti Pharmalabs Q2 Results
The FY27 outlook after Aarti Pharmalabs Q2 Results depends on how the next quarters compare with this one. The outlook therefore rests on the quarterly record: consolidated revenue of Rs 610.45 Cr and net profit of Rs 71.47 Cr set the base that later quarters will be measured against.
In this results analysis, the margin of 11.7% is the number to carry forward, along with the 155.98% rise in net profit. Full-year FY27 results will depend on subsequent quarters and on how steady the profit line stays, which leads directly to the risks that investors should weigh.
Key Risks to Watch After Aarti Pharmalabs Q2 Results FY27
Low Return on Equity
Return on equity was low at 8.50% in FY26. A return at that level is modest next to the YoY growth of 155.98% in quarterly net profit, so investors may want to see whether the latest quarter lifts the full-year return.
Long-Term Per-Share Profit Decline
Annual per-share profit has slipped sharply between FY22 and FY26. This long-term pattern sits behind the latest quarter, and it means the recent rise in net profit is being read against a weaker multi-year record.
Volatile Quarterly Net Profit
Quarterly net profit has been volatile, ranging from Rs 27.92 Cr to Rs 76.14 Cr over the last 5 quarters. After Aarti Pharmalabs Q2 Results FY27, the swings in YoY growth from quarter to quarter remain a point to track.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
The Aarti Pharmalabs Q2 Results FY27 show consolidated revenue of Rs 610.45 Cr, Operating Profit of Rs 135.16 Cr and net profit of Rs 71.47 Cr, all higher than a year earlier. Read together, the quarterly results and the Aarti Pharmalabs Q2 Results consolidated results describe faster profit growth than revenue growth. Investors should consult a SEBI-registered advisor before acting on any of these figures.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Aarti Pharmalabs Q2 Results FY27
What are Aarti Pharmalabs Q2 Results FY27?
Ans. The Aarti Pharmalabs Q2 Results FY27 are the consolidated quarterly results of Aarti Pharmalabs for July to September 2026, with revenue of Rs 610.45 Cr and net profit of Rs 71.47 Cr, as the Quick Answer summarises.
What is the results date for Aarti Pharmalabs Q2 Results FY27?
Ans. Aarti Pharmalabs declared its Q2 FY27 results on 28 October 2026, so the results date is 28 October 2026, which is the date the opening section of this article uses for the analysis.
What revenue was reported in Aarti Pharmalabs Q2 Results FY27?
Ans. Aarti Pharmalabs reported consolidated revenue of Rs 610.45 Cr in Q2 FY27, compared with Rs 418.33 Cr a year earlier, as the Financial Highlights table shows alongside the other metrics.
What net profit was reported in Aarti Pharmalabs Q2 Results FY27?
Ans. Aarti Pharmalabs reported consolidated net profit of Rs 71.47 Cr in Q2 FY27, while the same quarter last year showed Rs 27.92 Cr, as the Key Takeaways section explains.
How much YoY growth did revenue show in Aarti Pharmalabs Q2 Results FY27?
Ans. Revenue in Q2 FY27 grew 45.93% year on year to Rs 610.45 Cr, which means the top line expanded strongly, a move the Performance Analysis section reads in detail alongside profit.
Did net profit rise or fall in Aarti Pharmalabs Q2 Results?
Ans. Net profit rose in Aarti Pharmalabs Q2 Results, from Rs 27.92 Cr to Rs 71.47 Cr, a 155.98% increase, and this rise is larger than the revenue growth discussed in the Performance Analysis section.
What was the Operating Profit in Aarti Pharmalabs Q2 Results FY27?
Ans. Operating Profit was Rs 135.16 Cr in Q2 FY27 against Rs 74.72 Cr a year earlier, an 80.89% rise, while the Performance Analysis section compares it with revenue and net profit growth.
Are Aarti Pharmalabs Q2 Results consolidated results or standalone results?
Ans. The figures in Aarti Pharmalabs Q2 Results are consolidated results, which means they cover Aarti Pharmalabs together with its subsidiaries, and the Quick Answer and Conclusion sections state this basis again.
What business factors shaped Aarti Pharmalabs Q2 Results FY27?
Ans. Revenue growth of 45.9%, net profit growth of 156.0% and a margin of 11.7% against 6.7% are the disclosed factors, as the Key Business Factors section describes one by one.
What are the key risks after Aarti Pharmalabs Q2 Results FY27?
Ans. The disclosed risks are a low return on equity of 8.50% in FY26, a long-term fall in annual per-share profit and volatile quarterly net profit, which the Key Risks section covers in turn.
What is the outlook after Aarti Pharmalabs Q2 Results?
Ans. The outlook after Aarti Pharmalabs Q2 Results rests on how later quarters compare with this one, so the FY27 Outlook section uses the 11.7% margin and the 155.98% net profit rise as reference points.
Where can I find the complete Aarti Pharmalabs Q2 Results FY27 data?
Ans. The complete Aarti Pharmalabs Q2 Results FY27 data for revenue, Operating Profit and net profit sits in the Financial Highlights table above, and the Univest Screener lets you compare these consolidated results with other listed companies.
